Page 3 - Acrx News Today

StockNews.com assumed coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research report released on Sunday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. AcelRx Pharmaceuticals Trading Down 3.6 % Shares of NASDAQ ACRX opened at $1.07 on Friday. The stock has a market cap of $11.68 million, […]

StockNews.com assumed coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research note released on Sunday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. AcelRx Pharmaceuticals Trading Down 5.5 % Shares of ACRX stock opened at $1.21 on Friday. The company has a market capitalization of $13.21 […]

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX – Get Rating) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 765,800 shares, a decrease of 10.5% from the April 30th total of 855,800 shares. Based on an average trading volume of 204,900 shares, the short-interest ratio is currently 3.7 days. […]

AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Rating) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Thursday. AcelRx Pharmaceuticals Price Performance Shares of NASDAQ:ACRX traded up $0.08 on Thursday, reaching $0.79. 93,303 shares of the company traded hands, compared to its average […]

AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Rating) is set to release its earnings data after the market closes on Wednesday, May 10th. Analysts expect AcelRx Pharmaceuticals to post earnings of ($0.71) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. AcelRx Pharmaceuticals (NASDAQ:ACRX […]

StockNews.com upgraded shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Rating) from a sell rating to a hold rating in a research report report published on Friday. AcelRx Pharmaceuticals Price Performance ACRX stock opened at $0.64 on Friday. The company’s 50-day moving average is $1.21 and its 200-day moving average is $2.72. The stock has a […]

AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Rating) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Friday. AcelRx Pharmaceuticals Stock Down 0.8 % Shares of NASDAQ ACRX traded down $0.01 during midday trading on Friday, hitting $0.62. The stock had a […]

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX – Get Rating) – Investment analysts at Cantor Fitzgerald cut their FY2023 earnings estimates for AcelRx Pharmaceuticals in a research report issued on Monday, April 3rd. Cantor Fitzgerald analyst B. Folkes now expects that the specialty pharmaceutical company will post earnings per share of ($2.41) for the year, down from their […]

AcelRx Pharmaceuticals (NASDAQ: ACRX) recently received a number of ratings updates from brokerages and research firms: 5/21/2022 – AcelRx Pharmaceuticals is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 5/19/2022 – AcelRx Pharmaceuticals was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. […]

StockNews.com began coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Rating) in a research report issued on Thursday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. A number of other brokerages have also weighed in on ACRX. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of AcelRx Pharmaceuticals in a […]